| Name | Walgreens #17379 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 107 E Main St, Wilmington, Vermont 05363 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (802) 464-7575 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
There is growing recognition in this country that health depends largely on what happens outside of traditional health care settings—in the places where we live, learn, work, and play. Since many adults spend most of their waking lives at work, offices and worksites present a prime opportunity for improving health.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts and possible vaccine supply efforts to the government of South Korea for Sinovac's H1N1 vaccine.
A study led by environmental health researchers at the University of Cincinnati College of Medicine finds that children in East Liverpool, Ohio with higher levels of Manganese (Mn) had lower IQ scores. The research appears online in the journal NeuroToxicology, available in advance of publication.
Varicose vein disease is an underappreciated and often misunderstood medical condition, causing many individuals to be misdiagnosed, mistreated - or ignored - resulting in needless suffering and complications from progressively worsening symptoms. Unfortunately, patients typically wait until the disease reaches a more difficult to treat and debilitating stage: they have lifestyle limiting pain, unsightly bulging veins and spider veins, leg swelling or skin ulceration.
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
› Verified 3 days ago
| NPI Number | 1376067918 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #17379 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 107 E Main St, Wilmington, VT 05363 |
| Phone Number | 802-464-7575 |
News Archive
There is growing recognition in this country that health depends largely on what happens outside of traditional health care settings—in the places where we live, learn, work, and play. Since many adults spend most of their waking lives at work, offices and worksites present a prime opportunity for improving health.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts and possible vaccine supply efforts to the government of South Korea for Sinovac's H1N1 vaccine.
A study led by environmental health researchers at the University of Cincinnati College of Medicine finds that children in East Liverpool, Ohio with higher levels of Manganese (Mn) had lower IQ scores. The research appears online in the journal NeuroToxicology, available in advance of publication.
Varicose vein disease is an underappreciated and often misunderstood medical condition, causing many individuals to be misdiagnosed, mistreated - or ignored - resulting in needless suffering and complications from progressively worsening symptoms. Unfortunately, patients typically wait until the disease reaches a more difficult to treat and debilitating stage: they have lifestyle limiting pain, unsightly bulging veins and spider veins, leg swelling or skin ulceration.
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
› Verified 3 days ago
News Archive
There is growing recognition in this country that health depends largely on what happens outside of traditional health care settings—in the places where we live, learn, work, and play. Since many adults spend most of their waking lives at work, offices and worksites present a prime opportunity for improving health.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts and possible vaccine supply efforts to the government of South Korea for Sinovac's H1N1 vaccine.
A study led by environmental health researchers at the University of Cincinnati College of Medicine finds that children in East Liverpool, Ohio with higher levels of Manganese (Mn) had lower IQ scores. The research appears online in the journal NeuroToxicology, available in advance of publication.
Varicose vein disease is an underappreciated and often misunderstood medical condition, causing many individuals to be misdiagnosed, mistreated - or ignored - resulting in needless suffering and complications from progressively worsening symptoms. Unfortunately, patients typically wait until the disease reaches a more difficult to treat and debilitating stage: they have lifestyle limiting pain, unsightly bulging veins and spider veins, leg swelling or skin ulceration.
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
› Verified 3 days ago
Walgreens #17379 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 107 E Main St, Wilmington, Vermont 05363 Phone: (802) 464-7575 |